Ado-Trastuzumab Emtansine (Kadcyla) for HER2-Positive Metastatic Breast Cancer

被引：0
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2013年 / 55卷 / 1425期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：75 / 76
页数：2
相关论文
共 4 条
  • [1] New therapies in HER2-positive breast cancer: A major step towards a cure of the disease?
    Awada, Ahmad
    Bozovic-Spasojevic, Ivana
    Chow, Louis
    [J]. CANCER TREATMENT REVIEWS, 2012, 38 (05) : 494 - 504
  • [2] Population-based Estimate of the Prevalence of HER-2 Positive Breast Cancer Tumors for Early Stage Patients in the US
    Cronin, Kathleen A.
    Harlan, Linda C.
    Dodd, Kevin W.
    Abrams, Jeffrey S.
    Ballard-Barbash, Rachel
    [J]. CANCER INVESTIGATION, 2010, 28 (09) : 963 - 968
  • [3] Beyond trastuzumab: New treatment options for HER2-positive breast cancer
    Saini, Kamal S.
    Azim, Hatem A., Jr.
    Metzger-Filho, Otto
    Loi, Sherene
    Sotiriou, Christos
    de Azambuja, Evandro
    Piccart, Martine
    [J]. BREAST, 2011, 20 : S20 - S27
  • [4] Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
    Verma, Sunil
    Miles, David
    Gianni, Luca
    Krop, Ian E.
    Welslau, Manfred
    Baselga, Jose
    Pegram, Mark
    Oh, Do-Youn
    Dieras, Veronique
    Guardino, Ellie
    Fang, Liang
    Lu, Michael W.
    Olsen, Steven
    Blackwell, Kim
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (19) : 1783 - 1791
1